ArticleThe Lancet regional health. Europe2025

Clinical utility of the Fibrosis-4 index for predicting mortality in patients with heart failure with or without metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.

Joost Boeckmans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.